| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2023 | BVS Bioventus Inc. | Bartholdson John A.52 | Director, 10% Owner | Buy | 111,848 | $4.47 | $500,419.14 | +1.7% | -16.6% | +66.1% | |
| Aug 10, 2023 | EMBC Embecta Corp. | Mann Jeffrey Z | SVP, GC, Head Corp. Dev., Secy | Buy | 4,700 | $21.67 | $101,849.00 | +9.3% | -26.3% | -26.1% | |
| Aug 10, 2023 | EMBC Embecta Corp. | Elguicze Jacob | SVP And CFO | Buy | 4,625 | $21.66 | $100,194.61 | +7.5% | -26.3% | -26.1% | |
| Aug 10, 2023 | ATR Aptargroup, Inc. | Chainey Kimberly49 | EVP And Chief Legal Officer | Sell | 1,420 | $122.84 | $174,438.05 | -16.5% | +2.4% | +17.8% | |
| Aug 10, 2023 | AHCO Adapthealth Corp. | Clemens Jason A | Chief Financial Officer | Buy | 720 | $14.10 | $10,152.00 | +0.4% | -53.6% | -32.7% | |
| Aug 10, 2023 | ATR Aptargroup, Inc. | Fotiades George L46 | Director | Sell | 7,940 | $122.01 | $968,760.19 | -61.5% | +2.4% | +17.8% | |
| Aug 10, 2023 | EMBC Embecta Corp. | Kurdikar Devdatt | President And CEO | Buy | 5,000 | $21.81 | $109,050.00 | +2.1% | -26.3% | -26.1% | |
| Aug 10, 2023 | SSKN Strata Skin Sciences, Inc. | Lesovitz Christopher | Chief Financial Officer | Buy | 15,151 | $0.67 | $10,152.68 | +29.5% | -37.3% | -53.1% | |
| Aug 10, 2023 | SSKN Strata Skin Sciences, Inc. | Moccia Robert Joseph | Chief Executive Officer | Buy | 42,000 | $0.67 | $28,308.00 | +21.7% | -37.3% | -53.1% | |
| Aug 10, 2023 | AHCO Adapthealth Corp. | Prast Albert A. | Chief Technology Officer | Sell | 200,000 | $14.18 | $2,836,179.00 | -46.9% | -53.6% | -32.7% | |
| Aug 10, 2023 | EW Edwards Lifesciences Corp | Stone Heisz Leslie55 | Director | Sell | 3,303 | $78.87 | $260,508.60 | -10.9% | -15.4% | -17.4% | |
| Aug 10, 2023 | ATEC Alphatec Holdings, Inc. | Pritzker Jennifer N.49 | 10% Owner | Buy | 5,750 | $15.11 | $86,882.00 | +7.4% | -29.3% | -57.8% | |
| Aug 10, 2023 | SYK Stryker Corp | Datar Srikant M.51 | Director | Sell | 750 | $286.23 | $214,670.93 | -11.0% | -2.9% | +15.8% | |
| Aug 9, 2023 | DXCM Dexcom Inc | Stern Sadie72 | EVP Chief Human Resources Offi | Sell | 392 | $110.71 | $43,398.32 | -0.5% | -14.2% | -35.6% | |
| Aug 9, 2023 | SIBN Si-Bone, Inc. | Freund John Gordon79 | Director | Sell | 30,000 | $20.54 | $616,197.00 | -22.4% | -15.3% | -29.6% | |
| Aug 9, 2023 | BLFS Biolife Solutions Inc | Casdin Partners Master Fund, L.P.53 | 10% Owner | Buy | 58,465 | $13.20 | $771,743.85 | +0.8% | -11.6% | +73.5% | |
| Aug 9, 2023 | IART Integra Lifesciences Holdings Corp | Mosebrook Jeffrey70 | SVP, Fin &Pao | Sell | 1,177 | $44.46 | $52,329.42 | -4.8% | -14.3% | -50.8% | |
| Aug 9, 2023 | IRTC Irhythm Holdings, Inc. | Bobzien Brice49 | Chief Financial Officer | Sell | 1,356 | $111.29 | $150,909.24 | -6.8% | -27.0% | -37.3% | |
| Aug 9, 2023 | MMSI Merit Medical Systems Inc | Anderson A Scott50 | Director | Sell | 22,180 | $69.40 | $1,539,292.00 | -31.1% | +3.3% | +30.8% | |
| Aug 9, 2023 | ATR Aptargroup, Inc. | Gong Xiangwei57 | President, Asia | Sell | 3,000 | $123.13 | $369,398.70 | -14.4% | +2.2% | +19.5% | |
| Aug 9, 2023 | EW Edwards Lifesciences Corp | Szyman Catherine M.67 | Cvp, Critical Care | Sell | 5,000 | $78.64 | $393,185.00 | -12.6% | -14.7% | -18.8% | |
| Aug 8, 2023 | BRKR Bruker Corp | Laukien Frank H65 | President &CEO | Sell | 37,947 | $64.81 | $2,459,345.07 | - | -14.4% | -8.1% | |
| Aug 8, 2023 | SRTS Sensus Healthcare, Inc. | Sardano Michael73 | President And General Counsel | Buy | 1,000 | $3.78 | $3,777.80 | +1.8% | -42.7% | +51.4% | |
| Aug 8, 2023 | SRTS Sensus Healthcare, Inc. | Sardano Joseph C81 | Chief Executive Officer | Buy | 10,000 | $3.86 | $38,574.00 | +0.9% | -42.7% | +51.4% | |
| Aug 8, 2023 | RPID Rapid Micro Biosystems, Inc. | Spignesi Robert G. Jr.53 | President And CEO | Buy | 34,000 | $0.92 | $31,446.60 | +10.6% | +15.4% | -17.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.